GlassScriptPhysician profile
Regis L Renard
NPI 1730385741
$27,310.82
in general payments reported to CMS, 2019-2025
13 companies · $1,223 in 2025
The $1,223 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $522 · 2023: $8,042 · 2024: $17K · 2025: $1,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $4,675 · Food and Beverage: $3,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,840.00 |
| Travel and Lodging | $4,674.91 |
| Food and Beverage | $3,110.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $16,039.39 | 2023-2025 | Truelok, Galaxy Fixation System, Fitbone |
| Synthes USA Products LLC | $6,045.18 | 2023 | |
| Stryker Corporation | $4,357.46 | 2021-2025 | Pro, T2 Alpha, Gamma |
| Novastep INC. | $148.12 | 2022 | |
| Illuminoss Medical, INC. | $124.67 | 2023-2024 | Photodynamic Bone Stabilization Procedure Pack |
| Acumed LLC | $104.52 | 2023 | Acumed |
| Curvafix, INC. | $98.98 | 2022 | |
| Si-Bone, INC. | $90.87 | 2023 | |
| Cerapedics INC. | $89.23 | 2022 | |
| Depuy Synthes Sales INC. | $77.96 | 2023-2025 | Na |
| US Implant Solutions, LLC | $66.20 | 2024 | |
| Integra Lifesciences Corporation | $41.06 | 2021 | |
| Midsouth Orthopedics INC. | $27.18 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regis Renard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.